Researchers have developed a generic test for cancer and partnered with a tech company to bring it to market.

They believe that this test could be the first screening tool to detect cancer.

Cancer is one of the leading causes of death worldwide.

According to the American Institute for Cancer Research, there were about 18 million cancer cases diagnosed around the world in 2018.

The number of new cancer cases per year is expected to reach more than 23 million by 2030. The most common cancers globally are lung cancer, breast cancer, and colorectal cancer.

Lung and breast cancers contributed to 12.3 percent of the 18 million cases diagnosed in 2018, with more than 2 million cases, respectively.

Colorectal cancer is in third place with almost 2 million new cases diagnosed in 2018.

Doctors can diagnose cancers in a variety of ways. The most common methods include laboratory tests (blood, urine, and others), biopsy, endoscopy, genetic tests, and imaging tests, such as X-ray, MRI, and ultrasound.

For earlier diagnosis, researchers at the University of Bradford in the United Kingdom have introduced new "universal" blood test.

They believe that this new test could help detect cancer in people who doctors think may have the disease.

The research team partnered with a tech company to bring this revolutionary blood test to market.